Medical imaging generates critical efficacy and safety evidence across clinical trials. Yet fragmentation across image acquisition, quality control, data flow, and analysis continues to introduce significant operational and scientific bottlenecks.
Improving how imaging data is accessed, analyzed, and governed can help remove these constraints, enabling faster insights and more confident decision-making in drug development. Join us for a valuable discussion on the latest approaches for addressing these challenges.
In this webinar from Fierce Pharma, we’ll explore the modernization of imaging data management, with an important look at how life sciences organizations can successfully:
- Reduce time and resource burdens associated with image curation, quality assurance, and annotation validation
- Improve the speed and reliability of imaging data access across research partners and third parties
- Establish more centralized, scalable workflows to support research, advanced analytics, and emerging AI applications
- Strengthen data governance across complex imaging datasets
Speakers
Shelby Wyatt, PhD
Chief Product Officer
Flywheel
Shelby brings 20 years of experience leading cross-functional teams across Global BioPharma and technology companies with deep expertise in integrating advanced imaging technologies to accelerate drug development and improve patient care. As Chief Product Officer at Flywheel, Shelby is responsible for product strategy, partnerships, and marketing across BioPharma, Academic Medical Centers and MedDevice/MedTech. Previously, Shelby spent 13 years at Genentech/Roche in technical, strategic and operational roles, culminating in building and scaling Roche’s Global Imaging Platform.
Farshid Sepehrband, PhD
Head, Clinical Imaging Informatics and Data Sciences, Director, Clinical Imaging, Translational Medicine
Regeneron Pharmaceuticals, Inc.
Farshid Sepehrband, PhD, is a computational neuroscientist and biotechnologist specializing in neuroimaging, biomarker development, and the application of AI to medical imaging. Following postdoctoral training across neurological disorders and imaging AI, he joined the Department of Neurology at the University of Southern California and the Mark and Mary Stevens Neuroimaging and Informatics Institute, where he led an NIH-funded lab. He joined Regeneron in 2021 and is currently Director of Clinical Imaging and Head of the Clinical Imaging Informatics and Data Sciences (CIIDS) team.
